Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.
Viral vector-based gene therapies offer hope for complex conditions. Discover an advanced AAV producer cell line that is revolutionizing scalable, efficient, and accessible gene therapy production.
Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.
This website uses cookies to ensure you get the best experience on our website. Learn more
